DFX Intelligence

Data Factory

K•••••• B••••••: company on the venture capital graph | DFX Data Factory

The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.

VentureCompany

K•••••• B••••••

K•••••• B•••••• is a gene therapy biotechnology company focused on developing and delivering medicines to patients with genetic life-threatening or rare diseases using an HSV-1 based gene delivery platform.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:549c8201-8efd-4c9b-92f0-febab199be1c

Data as of Sep 20, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 22, 2026, 2:07 AM UTC and rebuilt at most every 15 minutes.

Relationships: 1
Dated events: 0
On other graphs: 1
Observed: Sep 14, 2026 to Sep 20, 2026
5 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

K•••••• B••••••

Portfolio company · cited

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 0
Investors: 1
People: 0
Website: krystalbio.com

Investors

Investor	Class	Fund	Partner	Role	Attribution
A•••• C•••••• A••••••• L••	Institutional VC	n/a	n/a	unknown	Unknown

Relationships

Invested in (1)

← A•••• C•••••• A••••••• L••FirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site

Dated events

No dated event names this entity yet.

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:549c8201-8efd-4c9b-92f0-febab199be1c
First observed: Sep 14, 2026
Last observed: Sep 20, 2026 39 h ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.